TEMPUS - Trademark Details
Status: 730 - First Extension - Granted
Serial Number
88783933
Word Mark
TEMPUS
Status
730 - First Extension - Granted
Status Date
2021-09-09
Filing Date
2020-02-04
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-03-09
Attorney Name
Law Office Assigned Location Code
M30
Employee Name
CORWIN, KEVIN SCOTT
Statements
Goods and Services
Artificial intelligence and machine learning-enabled computer software supporting clinical data platforms for diagnostics and medical, clinical and research testing in the fields of diabetes, neurology, psychiatry, and depression
Goods and Services
Medical research in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research related to diabetes, neurology, and depression diagnostics and testing; providing medical and scientific research information in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research in the fields of diabetes, neurology, and depression diagnostics and testing; research and development services in the fields of diabetes, neurology, and depression diagnostics and testing; Computer system analysis for use in diabetes, neurology, and depression diagnostics and testing; computer system design for use in diabetes, neurology, and depression diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of diabetes, neurology, and depression diagnostics and testing; Platform as a service (PAAS) featuring computer software platforms for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Platform as a service (PAAS) for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software using artificial intelligence for machine learning to support clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing; platform as a service (PAAS) featuring software using artificial intelligence for machine learning to support clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing
Goods and Services
Medical services in the field of diabetes, neurology, and depression diagnostics and testing; providing medical information in the fields of diabetes, neurology, and depression diagnostics and testing
Pseudo Mark
TEMP US
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-02-07
Primary Code
042
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Jeremy D. Bisdorf
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Child | 88979751 |
Madrid International Filings
Entry Number
1
Reference Number
A0094307
Original Filing Date USPTO
2020-02-17
International Registration Number
1527116
International Registration Date
2020-02-17
International Status Code
480
International Renewal Date
2030-02-17
Madrid History Events | ||
Date | Code | Description |
2020-12-25 | PDBNX | DIVISION OF BASE APPLICATION PROCESSED BY IB |
2020-04-23 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
2020-05-04 | SDRCV | SUBSEQUENT DESIGNATION RECEIVED |
2020-05-04 | SDSNT | SUBSEQUENT DESIGNATION SENT TO IB |
2020-05-29 | PEXNX | SUBSEQUENT DESIGNATION PROCESSED BY IB |
2020-02-17 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
2020-12-07 | DBCSP | DIVISIONAL OF BASE APP NOTICE SENT TO IB |
2020-02-21 | MCERT | MANUALLY CERTIFIED |
2020-02-21 | APPST | IR CERTIFIED AND SENT TO IB |
2020-12-05 | DBCRP | DIVISIONAL OF BASE APP NOTICE CREATED, TO BE SENT TO IB |
Trademark Events
Event Date | Event Description |
2020-02-07 | NEW APPLICATION ENTERED IN TRAM |
2020-02-07 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-03-28 | ASSIGNED TO EXAMINER |
2020-03-30 | NON-FINAL ACTION WRITTEN |
2020-03-30 | NON-FINAL ACTION E-MAILED |
2020-03-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-07-21 | TEAS REQUEST TO DIVIDE RECEIVED |
2020-08-04 | ASSIGNED TO LIE |
2020-08-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-10-08 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-10-14 | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST |
2020-10-23 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2020-11-17 | ASSIGNED TO LIE |
2020-11-30 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-11-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-07-21 | DIVISIONAL REQUEST RECEIVED |
2020-12-04 | DIVISIONAL PROCESSING COMPLETE |
2021-01-19 | NON-FINAL ACTION WRITTEN |
2021-01-19 | NON-FINAL ACTION E-MAILED |
2021-01-19 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-02-03 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-03 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-02-03 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-02-04 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-02-17 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-03-09 | PUBLISHED FOR OPPOSITION |
2021-03-09 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-05-04 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2021-09-09 | TEAS EXTENSION RECEIVED |
2021-09-09 | EXTENSION 1 FILED |
2021-09-09 | EXTENSION 1 GRANTED |
2021-09-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |